Treatment of Tourette Syndrome

Neurotherapeutics

Volumn 11, Issue 1, 2014, Pages 161-165

  Kurlan, Roger M ^a  

^a Overlook Medical Center   (United States)

Author keywords

Botulinum toxin; Deep brain stimulation; Medications; Tics; Tourette syndrome; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ACETYLCHOLINE; ADENOSINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; BACLOFEN; BOTULINUM TOXIN; CLONAZEPAM; CLONIDINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; FLUPHENAZINE; GLUTAMIC ACID; GUANFACINE; HALOPERIDOL; HISTAMINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; NORADRENALIN; OLANZAPINE; OPIATE; PARVALBUMIN; PIMOZIDE; PRAMIPEXOLE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TETRABENAZINE; TOPIRAMATE;

ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BRAIN DEPTH STIMULATION; CHOLINERGIC NERVE CELL; COGNITIVE THERAPY; COMORBIDITY; GILLES DE LA TOURETTE SYNDROME; HUMAN; NEUROTRANSMISSION; OBSESSIVE COMPULSIVE DISORDER; PATHOGENESIS; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; TIC; TREATMENT RESPONSE;

DEEP BRAIN STIMULATION; HUMANS; TOURETTE SYNDROME;

EID: 84893100212     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-013-0215-4     Document Type: Review

References (31)

1. Cheung M-YC, Shahed J, Jankovic J. Malignant Tourette syndrome. Movement Disord. 2007; 22(12): 1743-50.
2. Jankovic J, Kurlan R. Tourette syndrome: Evolving concepts. Movement Disord. 2011; 26(6): 1149-56.
3. Bronfeld M, Bar-Gad I. Tic Disorders: What Happens in the Basal Ganglia? Neuroscientist. 2013; 19(1): 101-8.
4. Orth M, Münchau A, Rothwell JC. Corticospinal system excitability at rest is associated with tic severity in Tourette syndrome. Biol Psychiat. 2008; 64(3): 248-51.
5. Rajagopal S, Seri and S, Cavanna AE. Premonitory urges and sensorimotor processing in Tourette syndrome. Behav Neurol. 2013; 27(1): 65-73.
6. Kataoka Y, Kalanithi PSA, Grantz H, Schwartz ML, Saper C, Leckman JF, et al. Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. The J Compar Neurol. 2010; 518(3): 277-91.
7. Kalanithi PSA, Zheng W, Kataoka Y, DiFiglia M, Grantz H, Saper CB, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(37): 13307-12.
8. Lerner A, Bagic A, Simmons JM, Mari Z, Bonne O, Xu B, et al. Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome. Brain. 2012; 135(6): 1926-36.
9. Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder. JAMA. 2010; 303(19): 1929-37.
10. Roessner V, Plessen K, Rothenberger A, Ludolph A, Rizzo R, Skov L, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiat. 2011; 20(4): 173-96.
11. Scahill L, Erenberg G, Berlin Jr CM, Budman C, Coffey BJ, Jankovic J, et al. Contemporary Assessment and Pharmacotherapy of Tourette Syndrome. NeuroRX. 2006; 3(2): 192-206.
12. Tourette's Syndrome Study Group. Short-term versus longer term pimozide therapy in Tourette's syndrome. Neurology. 1999; 52: 874-7.
13. Müller-Vahl KR, Krueger D. Does Tourette syndrome prevent tardive dyskinesia? Movement Disord. 2011; 26(13): 2442-3.
14. Dion Y, Annabele L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial. J Clin Psychopharm. 2002; 22: 31-9.
15. Scahill L, Leckman JF, Schultz RT, Katsovich L, Peterson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003; 69: 1130-5.
16. Peña MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to aripiprazole. Movement Disord. 2011; 26(1): 147-52.
17. Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and ADHD. Am J Psychiatry. 2001; 158: 1067-74.
18. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ. Clonidine treatment of Gilles de la Tourette syndrome. Arch Gen Psychiatry. 1991; 48: 324-8.
19. Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D. Tourettes Syndrome and Role of Tetrabenazine: Review and Personal Experience. Clin Drug Invest. 2008; 28(7): 443-59.
20. Kenney CJ, Hunter CB, Mejia NI, Jankovic J. Tetrabenazine in the treatment of Tourette syndrome. J Ped Neurol. 2007; 5(1): 9-13.
21. Jimenez-Shahed J, Jankovic J. Tetrabenazine for treatment of chorea associated with Huntington's disease and other potential indications. Expert Opinion on Orphan Drugs. 2013; 1(5): 423-36.
22. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosur Ps. 2010; 81(1): 70-3.
23. Kurlan R, Crespi G, Coffey B, Muller-Vahl K, Koval S, Wunderlich G, Pramipexole for TS Trial Investigators. A multi-center randomized placebo-controlled trial of pramipexole in Tourette's syndrome. Movement Disord. 2012; 27: 775-8.
24. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol. 2000; 57(8): 1190-3.
25. Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review). Neurology. 2008; 70(19): 1699-706.
26. Maciunas RJ, Maddux BN, Riley DE, Whitney CM, Schoenberg MR, Ogrocki PJ, et al. Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome. J Neurosurg. 2007; 107(5): 1004-14.
27. Servello D, Porta M, Sassi M, Brambilla A, Robertson MM. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosur Ps. 2008; 79(2): 136-42.
28. Viswanathan A, Jimenez-Shahed J, Baizabal Carvallo JF, Jankovic J. Deep brain stimulation for Tourette syndrome: target selection. Stereotactic and Functional Neurosurgery. 2012; 90(4): 213-24.
29. Tourette's Syndrome Study Group. Treatment of ADHD in children with Tourette's syndrome (TACT Trial). Ann Neurol. 2000; 48: 953.
30. Gadow KD, Sverd J, Nolan EE, Sprafkin J, Schneider J. Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 840-8.
31. Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW, et al. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology. 2005; 65(12): 1941-9.